Back
First Trust NASDAQ Technology Dividend Index Fund Vs. Akero Therapeutics Industry Stock Comparison
Buy
53
TDIV
First Trust NASDAQ Technology Dividend Index Fund
Last Price:
$92.50
Seasonality Move:
1.23%
Buy
53
AKRO
Akero Therapeutics
Last Price:
$50.14
Seasonality Move:
26.87%
Buy
53
First Trust NASDAQ Technology Dividend Index Fund (TDIV)
is a Buy
Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?
-
The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $92.70. The Score for TDIV is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
TDIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $48.31. The Score for AKRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TDIV Stock Price Chart
What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?
-
The First Trust NASDAQ Technology Dividend Index Fund share price today is $92.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $48.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
TDIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 24.06 | Buy |
Relative Strength Index (14 RSI): | 62.59 | Buy |
Chaikin Money Flow: | -22859 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.56 - 92.22) | Buy |
Bollinger Bands (100): | (73.9 - 90.62) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 42.94 | Sell |
Chaikin Money Flow: | 176266 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (48.58 - 52.42) | Sell |
Bollinger Bands (100): | (40.79 - 53.07) | Buy |
TDIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 91.11 | Buy |
20-day SMA: | 91.33 | Buy |
50-day SMA: | 89.56 | Buy |
200-day SMA: | 81.07 | Buy |
8-day EMA: | 86.99 | Buy |
20-day EMA: | 63.74 | Buy |
50-day EMA: | 34.72 | Buy |
200-day EMA: | 10.29 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.56 | Sell |
20-day SMA: | 50.04 | Sell |
50-day SMA: | 52.07 | Sell |
200-day SMA: | 41.69 | Buy |
8-day EMA: | 49.14 | Sell |
20-day EMA: | 49.91 | Sell |
50-day EMA: | 49.95 | Sell |
200-day EMA: | 42.9 | Buy |
First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.
First Trust NASDAQ Technology Dividend Index Fund Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |